絞り込み

16641

広告

XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America.

著者 Kreutz R , Mantovani LG , Haas S , Monje D , Schneider J , Bugge JP , Gebel M , Tamm M , Ageno W , Turpie AGG
Thromb Res.2019 Feb 13 ; 176():125-132.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (79view , 0users)

Full Text Sources

The prospective, non-interventional XALIA study investigated the safety and effectiveness of rivaroxaban and standard anticoagulation for the treatment of deep vein thrombosis (DVT). XALIA-LEA was conducted in regions not included in XALIA (Latin America, Eastern Europe, the Middle East, Africa, and the Asia-Pacific), and enrolled patients with isolated pulmonary embolism (PE).
PMID: 30825694 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード